Top news of the day from across the healthcare landscape.
Hepatitis/MASH
Latest News
Advertisement
CME Content
Advertisement
Top news of the day from across the healthcare landscape.
Hepatitis B virus is known to increase the risk of cirrhosis and hepatocellular carcinoma.
A hepatitis C virus diagnosis may curb drug use among those in treatment.
This year, the FDA is on pace to approve about 38 new medications. Here is a look at 4 of those.
Veterans may be up to 5 times more likely to have hepatitis C than the general population.
Top news of the day from across the healthcare landscape.
Top news of the day from across the healthcare landscape.
Patients with hepatitis C virus achieve treatment success with specialists, primary care physicians, and nurse practitioners.
The lack of association of SVR with ribavirin dose reflects the wide variance in plasma levels between individuals with hepatitis C receiving the same weight-based dosage.
Heart transplant patients with hepatitis C often cannot not tolerate interferon-based regimens due to cardiac toxicity and other heart-related problems.
Drinking coffee may have more profound survival benefits for patients with HIV and hepatitis C than for the general population.
Researchers continue to focus on developing an 8-week treatment regimen for hepatitis C virus.
Top news of the day from across the healthcare landscape.
Top news of the day from across the healthcare landscape.
A look at the top stories in pharmacy last week.
A look at the top stories in pharmacy last week.
Top news from across the healthcare landscape.
Top news from across the healthcare landscape.
Top news of the week from Specialty Pharmacy Times.
National brand spending and new patient rates for hepatitis C virus dropped last year.
The pharma giant will now focus on its PD-1 cancer immunotherapy Keytruda.
Ramping up programs for injection drug users is a key part in preventing transmission of hepatitis C.
Testing and treatment programs should focus on populations driving new cases of hepatitis C virus.
Trending News Today: Cash Reimbursements Offered to Customers Impacted by Aetna's HIV Privacy Breach
Top news of the day from across the health care landscape.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
2
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
3
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
4
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
5
